Sichuan Huaxin (Group) accounting firm address: 28th floor, jinmaolidu south, No. 18, Ximianqiao street, Chengdu (special general partnership) Tel: (028) 85560449
Fax: (028) 85560449
Si Chuan Hua Xin (Group) CPA 610041
(LLP) email: [email protected].
Chongqing Lummy Pharmaceutical Co.Ltd(300006)
On deduction of operating income
Special audit opinions
Chxs (2022) No. 0113
catalog:
1. Anti counterfeiting identification
2. Special audit opinions
3. Deduction of operating income in 2021
About 3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021
Special review opinions on deduction of operating income
Chuan Hua Xin Zhuan (2022) No. 0113 Chongqing Lummy Pharmaceutical Co.Ltd(300006) all shareholders:
We have been entrusted to audit the consolidated and parent company’s balance sheet of Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as ” Chongqing Lummy Pharmaceutical Co.Ltd(300006) “) as of December 31, 2021, consolidated and parent company’s income statement, consolidated and parent company’s cash flow statement, consolidated and parent company’s statement of changes in owner’s equity and notes to relevant financial statements in accordance with the auditing standards of Chinese certified public accountants, On March 24, 2022, the company issued the audit report with unqualified opinion of standard chxs (2022) No. 0012.
In accordance with the relevant provisions of the Shenzhen Stock Exchange GEM Listing Rules (revised in December 2020) (SZS [2020] No. 1292) (hereinafter referred to as the “Listing Rules”) and the Shenzhen Stock Exchange GEM listed companies self regulatory guide No. 1 – business handling (SZS [2022] No. 28), Chongqing Lummy Pharmaceutical Co.Ltd(300006) management has prepared the attached statement of deduction of operating income in 3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021 (hereinafter referred to as “statement of deduction of operating income”). It is the responsibility of Chongqing Lummy Pharmaceutical Co.Ltd(300006) management to prepare and disclose the statement of deduction of operating income in accordance with the listing rules and ensure its authenticity, accuracy and completeness. We checked the information contained in the statement of operating income deduction with the accounting data and relevant contents of the audited financial statements when we audited the financial statements of 3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021, and found no inconsistency in all major aspects. We believe that the deduction of 3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021 annual operating income complies with the relevant provisions of the listing rules.
In order to better understand Chongqing Lummy Pharmaceutical Co.Ltd(300006) operating income and its deduction, the statement of deduction of operating income should be read together with the audited financial statements.
This special audit opinion is only used for the purpose of disclosure of Chongqing Lummy Pharmaceutical Co.Ltd(300006) annual report, and shall not be used for other purposes without the written consent of the accounting firm.
Attached table 1: deduction of 3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021 annual operating income
Sichuan Huaxin (Group) certified public accountants China Certified Public Accountant: Chen Jie
(special general partnership)
Chengdu, China Certified Public Accountant: Li Youming
Chinese certified public accountant: Zhao Xiangyu
March 24, 2002
3 Shenzhen Huaqiang Industry Co.Ltd(000062) 021 operating income deduction statement
